Our team includes pioneers in genome editing and leaders in cell and gene therapy who are committed to solving significant medical problems. LeadershipBoard of DirectorsScientific Advisors Michael AmorosoPresident, Chief Executive Officer Jeff Smith, Ph.D.Chief Research Officer Cindy AtwellChief Business Officer Juli BlancheChief People Officer Alex KellyChief Financial Officer Neil LeatherburySenior Vice President of Chemistry, Manufacturing, and Controls (CMC) Alan List, M.D.Chief Medical Officer Dario ScimecaGeneral Counsel Kevin Buehler Michael AmorosoPresident, Chief Executive Officer Melinda Brown Stanley Frankel, M.D. Geno Germano Shari Lisa Piré, J.D. Sam Wadsworth, Ph.D. Derek Jantz, Ph.D. Raymond Schinazi, Ph.D., DSc
